InterWest Venture Management’s Neuronetics STIM Stock Holding History

InterWest Venture Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-497,158	Closed	-$6.15M	–	12
2021 Q1	$6.15M	Sell	497,158 -497,157	-50%	-$7.62M	1.62%	7
2020 Q4	$11M	Sell	994,315 -36,374	-4%	-$273K	1.38%	5
2020 Q3	$5.01M	Hold	1,030,689	–	–	1.45%	6
2020 Q2	$1.99M	Hold	1,030,689	–	–	1.65%	8
2020 Q1	$1.95M	Hold	1,030,689	–	–	2.06%	9
2019 Q4	$4.63M	Hold	1,030,689	–	–	2%	8
2019 Q3	$8.56M	Hold	1,030,689	–	–	3.29%	4
2019 Q2	$12.9M	Hold	1,030,689	–	–	4.16%	4
2019 Q1	$15.7M	Hold	1,030,689	–	–	14.44%	3
2018 Q4	$19.9M	Hold	1,030,689	–	–	28%	1
2018 Q3	$33M	Hold	1,030,689	–	–	16.14%	2
2018 Q2	$27.4M	Buy	+1,030,689	New	+$28M	11.58%	3

Other funds holding STIM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

InterWest Venture Management's STIM Position: Q2 2021 in Review

InterWest Venture Management sold out of Neuronetics (STIM) in Q2 2021, closing a stake of 497,158 shares — an estimated $6.15M sold.

InterWest Venture Management first reported a position in STIM in Q2 2018 and held it in 12 quarters. The position peaked at $33M in Q3 2018. 105 funds tracked by Wall St. Rank hold STIM as of Q2 2021.

InterWest Venture Management reported no remaining Neuronetics position as of Q2 2021 after selling out during the quarter.
InterWest Venture Management sold 497,158 Neuronetics shares in Q2 2021, an estimated $6.15M.
InterWest Venture Management first reported a position in Neuronetics in Q2 2018 and held it in 12 quarters.
InterWest Venture Management's Neuronetics position peaked at $33M in Q3 2018.
105 funds tracked by Wall St. Rank held Neuronetics as of Q2 2021.

Based on InterWest Venture Management's 13F filing for Q2 2021, filed 26 Jul 2021.